Persistent Minority K103N Mutations among Women Exposed to Single‐Dose Nevirapine and Virologic Response to Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Therapy
Open Access
- 15 February 2009
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 48 (4), 462-472
- https://doi.org/10.1086/596486
Abstract
Objective. We investigated whether there are long-lasting effects of exposure to single-dose nevirapine (sdNVP) treatment on virologic response to noKeywords
This publication has 27 references indexed in Scilit:
- Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment EfficacyPLoS Medicine, 2008
- Improvement in allele-specific PCR assay with the use of polymorphism-specific primers for the analysis of minor variant drug resistance in HIV-1 subtype CJournal of Virological Methods, 2008
- A Radiolabeled Oligonucleotide Ligation Assay Demonstrates the High Frequency of Nevirapine Resistance Mutations in HIV Type 1 Quasispecies of NVP-Treated and Untreated Mother–Infant Pairs from UgandaAIDS Research and Human Retroviruses, 2008
- Site-specific interventions to improve prevention of mother-to-child transmission of human immunodeficiency virus programs in less developed settingsAmerican Journal of Obstetrics and Gynecology, 2007
- International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 updateAmerican Journal of Obstetrics and Gynecology, 2007
- Short Communication:HIV Type 1 Variants with Nevirapine Resistance Mutations Are Rarely Detected in Antiretroviral Drug-Naive African Women with Subtypes A, C, and DAIDS Research and Human Retroviruses, 2007
- Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapineAIDS, 2007
- Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmissionProceedings of the National Academy of Sciences, 2006
- Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmissionAIDS, 2006
- Impact of Human Immunodeficiency Virus Type 1 (HIV‐1) Subtype on Women Receiving Single‐Dose Nevirapine Prophylaxis to Prevent HIV‐1 Vertical Transmission (HIV Network for Prevention Trials 012 Study)The Journal of Infectious Diseases, 2001